As the toll of America’s opioid epidemic continues to mount, the University of Maryland School of Medicine announced the Kahlert Institute for Addiction Medicine, where researchers, substance use disorder specialists and doctors will work together to change the way addiction is treated, prevented and studied.
As the toll of America’s opioid epidemic continues to mount, the University of Maryland School of Medicine announced the Kahlert Institute for Addiction Medicine, where researchers, substance use disorder specialists and doctors will work together to change the way addiction is treated, prevented and studied.
The University of Maryland, Baltimore (UMB) is the state’s public health, law, and human services university devoted to excellence in professional and graduate education, research, patient care, and public service.
New research findings, published in March in the Journal of the American College of Cardiology, used data from the Coronary Artery Risk Development in Young Adults (CARDIA), which recruited about 5,000 healthy young adults from four U.S. cities and followed them for 30 years. The researchers were able to calculate from this data the cumulative effect of individual risk factors, such as high blood pressure, diabetes, elevated cholesterol, and the additive effects of multiple risk factors that can cause cardiovascular disease.